): The goal of the training grant entitled """"""""Research Training in Neuro-Oncology for Neurosurgeons"""""""" is to prepare neurosurgeons for academic careers in neuro-oncology. Applicants with M.D. degrees who have completed at least two years of postdoctoral training toward board certification in neurosurgery and are committed to a career in academic neuro-oncology are candidates for this research fellowship. Applicants are solicited through announcements in journals, meetings and mailings, interviewed by members of the Steering Committee, and selected on the basis of merit. Each trainee is provided with a unique two or three year neuro-oncology research training program. Trainees are involved in well- supervised, multidisciplinary research activities in one of the twenty-two participating research laboratories involved in neuro- oncologic research. These laboratories are located in the Oncology Center (Biostatistics, Cancer Pain, Cell and Gene Therapy, EB Virus/CNS Lymphoma, Epidemiology, Molecular Genetics, Neuro- Oncology, Pharmacology/ Experimental Therapeutics, and Radiation Oncology), and the Departments of Radiology (Diagnostic Radiology Research, Neuro-radiology, and Nuclear Medicine), Neurology and Neurosurgery (Brain Injury and Brain Interstitial Chemotherapy, Neural Micro-vascular Function, Pain Research, Pediatric Neurology, Pediatric Neuro-surgery, and Neurovirology), and Pathology (Cytogenetics and Neuropathology). The trainees also attend clinical and research conferences, seminars, and courses throughout The Johns Hopkins Medical Institutions that are relevant to neuro-oncology, their research activities, and their needs as future academicians.
| Blakeley, Jaishri O; Grossman, Stuart A; Chi, Andrew S et al. (2018) Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma. Clin Cancer Res : |
| Yovino, Susannah; Grossman, Stuart A (2012) Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas. CNS Oncol 1:149-54 |
| Chesler, David A; Berger, Mitchell S; Quinones-Hinojosa, Alfredo (2012) The potential origin of glioblastoma initiating cells. Front Biosci (Schol Ed) 4:190-205 |
| Agrawal, Nishant; Frederick, Mitchell J; Pickering, Curtis R et al. (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333:1154-7 |
| Chesler, D A; Pendleton, C; Jallo, G I et al. (2011) ""Colossal"" breakthrough: the callosal puncture as a precursor to third ventriculostomy. Minim Invasive Neurosurg 54:243-6 |
| Bettegowda, Chetan; Agrawal, Nishant; Jiao, Yuchen et al. (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333:1453-5 |
| Hsu, Wesley; Dorsi, Michael J; Witham, Timothy F (2009) Surgical Management of Cervical Spondylotic Myelopathy. Neurosurg Q 19:302-307 |
| Pradilla, Gustavo; Wang, Paul P; Gabikian, Patrik et al. (2006) Local intracerebral administration of Paclitaxel with the paclimer delivery system: toxicity study in a canine model. J Neurooncol 76:131-8 |
| Stearns, Duncan; Chaudhry, Aneeka; Abel, Ty W et al. (2006) c-myc overexpression causes anaplasia in medulloblastoma. Cancer Res 66:673-81 |
| Sampath, Prakash; Amundson, Eric; Wall, Monroe E et al. (2003) Camptothecin analogs in malignant gliomas: comparative analysis and characterization. J Neurosurg 98:570-7 |
Showing the most recent 10 out of 39 publications
